Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway, (Front. Pharmacol, (2020), 11, (554736), 10.3389/fphar.2020.554736)

doi:10.3389/fphar.2022.973989

科研成果详情

名称	Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway, (Front. Pharmacol, (2020), 11, (554736), 10.3389/fphar.2020.554736)
作者	Yu, Xingxing 1,2; Wang, Xin 1; Wang, Xu 3,4; Zhou, Yi 5; Li, Yanchun 6; Wang, Aiwei 7; Wang, Tongtong ; An, Yihan 1; Sun, Weidong 1; Du, Jing 4; Tong, Xiangmin 1,6,8; Wang, Ying 8
发表期刊	Frontiers in Pharmacology;
语种	英语
原始文献类型	Erratum
关键词	diffuse large B-cell lymphoma DNA damage p38 MAPK reactive oxygen species TEOA
摘要	In the published article, there was an error in Figures 3E, 4E as published. The images of Vehicle in Figure 3E and TEOA + GSH in Figure 4E were incorrect. The corrected Figures 3E, 4E and its caption appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
出版者	FRONTIERS MEDIA SA
ISSN	1663-9812
EISSN	1663-9812
卷号	13
DOI	10.3389/fphar.2022.973989
页数	3
WOS类目	Pharmacology & Pharmacy
WOS研究方向	Pharmacology & Pharmacy
WOS记录号	WOS:000845065300001
收录类别	SCOPUS ; SCIE
发布日期	2022-08-12
URL	查看原文
PubMed ID	36034812
通讯作者地址	[Tong, Xiangmin]Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Clin Res Inst, Peoples Hosp, Hangzhou, Peoples R China. ; [Du, Jing]Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Lab Med, Peoples Hosp, Hangzhou, Peoples R China. ; [Tong, Xiangmin]Zhejiang Chinese Med Univ, Clin Med Sch 2, Hangzhou, Zhejiang, Peoples R China. ; [Tong, Xiangmin;Wang, Ying]Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Phase Clin Res Ctr 1, Peoples Hosp, Hangzhou, Peoples R China.
Scopus学科分类	Pharmacology;Pharmacology (medical)
SCOPUSEID	SCOPUS_ID:85136892610
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184786
专题	检验医学院（生命科学学院、生物学实验教学中心）
通讯作者	Du, Jing; Tong, Xiangmin; Wang, Ying
作者单位	1.Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Clin Res Inst, Peoples Hosp, Hangzhou, Peoples R China; 2.Anhui Med Univ, Dept Hematol, Fuyang Hosp, Fuyang, Peoples R China; 3.Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China; 4.Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Lab Med, Peoples Hosp, Hangzhou, Peoples R China; 5.Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Wangjiangshan Inst, Peoples Hosp, Hangzhou, Peoples R China; 6.Zhejiang Chinese Med Univ, Clin Med Sch 2, Hangzhou, Zhejiang, Peoples R China; 7.First Peoples Hosp Fuyang, Dept Hematol, Hangzhou, Peoples R China; 8.Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Phase Clin Res Ctr 1, Peoples Hosp, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Yu, Xingxing,Wang, Xin,Wang, Xu,et al. Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway, (Front. Pharmacol, (2020), 11, (554736), 10.3389/fphar.2020.554736). 2022.